Wells Fargo’s IceCure Medical ICCM Stock Holding History

Wells Fargo’s Portfolio ICCM Stock Details ICCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-106	Closed	-$4.81K	–	7730
2022 Q4	$4.81K	Buy	+106	New	+$3.8K	﹤0.01%	5786

Other funds holding ICCM

BFM

Boothbay Fund Management New York $7.71B AUM 106.31% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

BCWM

Bartlett & Co Wealth Management Cincinnati, Ohio $7.99B AUM 20.76% 1-Year Est. Return

Wells Fargo's ICCM Position: Q1 2023 in Review

Wells Fargo sold out of IceCure Medical (ICCM) in Q1 2023, closing a stake of 106 shares — an estimated $4.81K sold.

Wells Fargo first reported a position in ICCM in Q4 2022 and held it in 1 quarter. The position peaked at $4.81K in Q4 2022. 8 funds tracked by Wall St. Rank hold ICCM as of Q1 2023.

Wells Fargo reported no remaining IceCure Medical position as of Q1 2023 after selling out during the quarter.
Wells Fargo sold 106 IceCure Medical shares in Q1 2023, an estimated $4.81K.
Wells Fargo first reported a position in IceCure Medical in Q4 2022 and held it in 1 quarter.
Wells Fargo's IceCure Medical position peaked at $4.81K in Q4 2022.
8 funds tracked by Wall St. Rank held IceCure Medical as of Q1 2023.

Based on Wells Fargo's 13F filing for Q1 2023, filed 12 May 2023.